Cargando…
Novel role of UHRF1 in the epigenetic repression of the latent HIV-1
BACKGROUND: The multiplicity, heterogeneity, and dynamic nature of human immunodeficiency virus type-1 (HIV-1) latency mechanisms are reflected in the current lack of functional cure for HIV-1. Accordingly, all classes of latency-reversing agents (LRAs) have been reported to present variable ex vivo...
Autores principales: | Verdikt, Roxane, Bendoumou, Maryam, Bouchat, Sophie, Nestola, Lorena, Pasternak, Alexander O., Darcis, Gilles, Avettand-Fenoel, Véronique, Vanhulle, Caroline, Aït-Ammar, Amina, Santangelo, Marion, Plant, Estelle, Douce, Valentin Le, Delacourt, Nadège, Cicilionytė, Aurelija, Necsoi, Coca, Corazza, Francis, Passaes, Caroline Pereira Bittencourt, Schwartz, Christian, Bizet, Martin, Fuks, François, Sáez-Cirión, Asier, Rouzioux, Christine, De Wit, Stéphane, Berkhout, Ben, Gautier, Virginie, Rohr, Olivier, Van Lint, Carine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038550/ https://www.ncbi.nlm.nih.gov/pubmed/35429693 http://dx.doi.org/10.1016/j.ebiom.2022.103985 |
Ejemplares similares
-
Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
por: Bouchat, Sophie, et al.
Publicado: (2015) -
Total HIV DNA: a global marker of HIV persistence
por: Rouzioux, Christine, et al.
Publicado: (2018) -
Pro-viral DNA and antiretroviral treatment simplification
por: Zucman, D, et al.
Publicado: (2010) -
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
por: Darcis, Gilles, et al.
Publicado: (2015) -
A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level
por: Canouï, Etienne, et al.
Publicado: (2017)